Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

The worldwide prevalence of cardiovascular disease in general and atherosclerotic coronary artery disease in particular is a health and economic concern of unparalleled proportion. Despite a long history of astute observations beginning in 1575 made by Fallopius, followed by those of von Rokatansky,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Coronary artery disease 2018-08, Vol.29 (5), p.429-437
Hauptverfasser:	Ali, Mahboob, Girgis, Sameh, Hassan, Atif, Rudick, Steven, Becker, Richard C
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Clinical Trials as Topic Coronary Artery Disease - drug therapy Coronary Artery Disease - immunology Coronary Artery Disease - metabolism Coronary Artery Disease - physiopathology Evidence-Based Medicine Humans Inflammation - drug therapy Inflammation - immunology Inflammation - metabolism Inflammation - physiopathology Inflammation Mediators - antagonists & inhibitors Inflammation Mediators - immunology Inflammation Mediators - metabolism Risk Factors Signal Transduction - drug effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!